EffRx Attending the BIO International Convention in San Diego

The BIO International Convention, taking place June 3-6, 2024, is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with more than 18,500 industry leaders from across the globe. EffRx proactively seeks in-licensing opportunities for Europe in niche therapeutic areas, primarily interested in rare diseases, endocrinology, and musculoskeletal diseases, and will […]

EffRx Attending the 2024 WCO IOF-ESCEO Congress in London

EffRx Pharmaceuticals is attending 24th Edition of the WCO-IOF-ESCEO – World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases – which takes place in London on April 11-14, 2024. EffRx will have a booth featuring Binosto® (buffered soluble alendronate 70mg), the first and only buffered solution for the treatment of osteoporosis. The IOF Congress is one […]

EffRx is a Proud Supporter of Rare Disease Day, Taking Place on February 28

As every year, EffRx will be recognizing and supporting the annual Rare Disease Day. Rare Disease Day is the globally coordinated movement on rare diseases, working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease. Since its creation in 2008, Rare Disease Day has played […]

EffRx Attending the Annual Meeting SSEDP / SGPED on 25. January 2024 in Berne

The Swiss Society for Pediatric Endocrinology and Diabetology (SGPED) comprises pediatric endocrinologists and individuals from allied health professions. EffRx, a sponsor of SGPED, is jointly committed to improving the care of children and adolescents with endocrinological diseases and diabetes mellitus. Every year, EffRx supported this annual meeting and was present with a booth showing the […]

World Orphan Drug Alliance (WODA) Marks their First Anniversary

EffRx-Newsroom-News-20230712

News World Orphan Drug Alliance (WODA) Marks their First Anniversary July 12, 2023 World Orphan Drug Alliance (WODA) Marks their First Anniversary Read more Contact Wolleraustrasse 41B, 8807 Freienbach, Switzerland +41 44 503 78 60 info@effrx.com SHARE THIS ARTICLE

EffRx Attends the WCO IOF-ESCEO Congress

EffRx-Newsroom-News-20230504

News EffRx Attends the WCO IOF-ESCEO Congress May 4, 2023 EffRx Attends the WCO IOF-ESCEO Congress EffRx Pharmaceuticals is attending the WCO IOF-ESCEO – World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases – which will take place from May 4 -7, 2023 in Barcelona, Spain. The IOF Congress is one of the most significant events […]

EffRx Supports the 16th Annual Rare Disease Day on 28. February 2023

EffRx-Newsroom-News-20230221

News EffRx Supports the 16th Annual Rare Disease Day on 28. February 2023 February 21, 2023 EffRx Supports the 16th Annual Rare Disease Day on 28. February 2023 The 16th international Rare Disease Day is on the 28th of February, 2023. Rare Disease Day is the official international awareness-raising campaign for rare diseases. Rare Disease […]

EffRx Attending the Annual Meeting SSEDP / SGPED on 26. January 2023 at the Universitäts-Kinderspital Zürich

EffRx-Newsroom-News-20230124

News EffRx Attending the Annual Meeting SSEDP / SGPED on 26. January 2023 at the Universitäts-Kinderspital Zürich January 24, 2023 EffRx Attending the Annual Meeting SSEDP / SGPED on 26. January 2023 at the Universitäts-Kinderspital Zürich The Swiss Society for Pediatric Endocrinology and Diabetology (SGPED) is composed of pediatric endocrinologists and individuals from allied health professions. Together […]